Testing Before Treating: Molecular Determinants of Optimal Therapy for NSCLC

Learn how experts optimally test for biomarkers in patients with NSCLC in this interactive text module with multidisciplinary perspectives from Matthew Gubens, MD, MS, a thoracic oncologist, and Craig Mackinnon, MD, PhD, an anatomical and molecular pathologist, and then use the results to integrate novel and emerging targeted therapies effectively and safely into clinical practice care.

Matthew Gubens, MD, MS Craig Mackinnon, MD, PhD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: July 6, 2022 Expired: July 5, 2023

Review this slideset on current recommendations for evidence-based biomarker testing to guide treatment decision-making for patients with NSCLC from Matthew Gubens, MD, MS, and Craig Mackinnon, MD, PhD.

Matthew Gubens, MD, MS Craig Mackinnon, MD, PhD Released: July 6, 2022